An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus
for Systemic Lupus Erythematosus (SLE)
36 locations incl. Phoenix
Sponsor: Biogen
Sex: All·Age: 18+
Code: NCT05352919·Phase 3·Enrolling By Invitation